KalVista Pharmaceuticals (KALV) EPS (Basic) (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -13.13% |
| Oct 31, 2024 | -4.60% |
| Jul 31, 2024 | 18.69% |
| Apr 30, 2024 | -27.38% |
| Jan 31, 2024 | -5.00% |
| Oct 31, 2023 | -8.11% |
| Jul 31, 2023 | 1.33% |
| Apr 30, 2023 | 0.00% |
| Jan 31, 2023 | 16.67% |
| Oct 31, 2022 | 4.26% |
| Jul 31, 2022 | 4.08% |
| Apr 30, 2022 | -6.52% |
| Jan 31, 2022 | -15.00% |
| Oct 31, 2021 | -21.21% |
| Jul 31, 2021 | 1.49% |
| Apr 30, 2021 | -19.64% |
| Jan 31, 2021 | 3.45% |
| Oct 31, 2020 | 4.92% |
| Jul 31, 2020 | -64.86% |
| Apr 30, 2020 | 28.85% |
| Jan 31, 2020 | -57.58% |
| Oct 31, 2019 | 21.43% |
| Jul 31, 2019 | 14.29% |
| Apr 30, 2019 | -113.04% |
| Jan 31, 2019 | -4.55% |
| Oct 31, 2018 | 53.19% |
| Jul 31, 2018 | -683.33% |
| Apr 30, 2018 | 87.76% |
| Jan 31, 2018 | 2.00% |
| Oct 31, 2017 | 1.96% |
| Jul 31, 2017 | -18.60% |
| Apr 30, 2017 | 58.25% |
| Jan 31, 2017 | 82.78% |
| Oct 31, 2016 | 10.21% |
| Mar 31, 2016 | -19.05% |
| Dec 31, 2015 | -10.53% |
| Sep 30, 2015 | 52.50% |
| Jun 30, 2015 | 94.58% |
| Mar 31, 2015 | -8.21% |
| Dec 31, 2014 | -15.79% |
| Sep 30, 2014 | -38.26% |
| Jun 30, 2014 | 2.96% |